Name | N-(3-chloro-4-fluorophenyl)-6-nitro-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine |
---|---|
Synonyms |
T66 BN DNJ EMR CG DF& HNW IO- CT5OTJ &&S Form
4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]- (S)-N-(3-chloro-4-fluorophenyl)-6-nitro-7-(tetrahydrofuran-3-yloxy)quinazolin-4-amine N-(3-Chloro-4-fluorophenyl)-6-nitro-7-[(3S)-tetrahydro-3-furanyloxy]-4-quinazolinamine N-(3-Chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4-quinazolinamine (S)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-[(tetrahydrofuran-3-yl)oxy]quinazolin-4-amine QC-4531 Afatinib Impurity 1 |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 585.0±50.0 °C at 760 mmHg |
Molecular Formula | C18H14ClFN4O4 |
Molecular Weight | 404.780 |
Flash Point | 307.6±30.1 °C |
Exact Mass | 404.068756 |
PSA | 102.09000 |
LogP | 3.59 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.693 |
Storage condition | 2-8°C |
Hazard Codes | Xn |
---|